University of California San Francisco

Suneil Koliwad, MD, PhD

suneil.koliwad
Suneil Koliwad, MD, PhD

Professor, Medicine
School of Medicine

Address

513 Parnassus Avenue MSB, #1230B
San Francisco, CA 94143
United States

Email: [email protected]

ORCID: 0000-0002-7367-1054

Education

Institution Degree Dept or School End Date
University of California Diversity, Equity, and Inclusion Champion Training 2021
UCSF Fellowship Diabetes, Endocrinology, and Metabolism 06/2006
Baylor College of Medicine Residency Internal Medicine/Pediatrics 06/2003
Baylor College of Medicine M.D. Medicine 05/1999
Baylor College of Medicine Ph.D. Molecular Physiology 05/1995
University of California Los Angeles B.S. Psychobiology 06/1992

Awards & Honors

Award Conferred By Date
Guenther Boden, MD Memorial Award Lecture Temple University School of Medicine 2024
Distinguished Endocrinologist Award Lecture University of California Irvine 2022
Election to American Society of Clinical Investigation American Society for Clinical Investigation (ASCI) 2018
Outstanding Postdoctoral Researcher J. David Gladstone Institutes 2011
A.P. Giannini Scholarship In Medical Research UCSF and J. David Gladstone Institutes 2006
Outstanding Resident Teaching Award Baylor College of Medicine 1999
Alpha Omega Alpha Medical Honor Society Baylor College of Medicine 1998

Collaboration Interests

I am interested in:

  • physician scientist

Clinical Trials

  1. Inflammation, Diabetes, Ethnicity and Obesity Cohort (NCT03022682)
    Related Conditions: Obesity, Diabetes, Glucose Intolerance| Start Date: | End Date:

Grants and Funding

  • Assessing the Interrelationship Between Adipose Tissue Thermogenesis and Fibrosis in the Metabolic Health of People Living with HIV | NIH/NIDDK | 2024-09-10 - 2029-06-30 | Role: Principal Investigator
  • Assessing the Interrelationship Between Adipose Tissue Thermogenesis and Fibrosis in the Metabolic Health of People Living with HIV | NIH | 2024-09-10 - 2029-06-30 | Role: Principal Investigator
  • Immunologic and Fat-Associated Predictors of Insulin Resistance in Treated HIV | NIH/NIDDK | 2017-07-20 - 2022-04-30 | Role: Co-Principal Investigator
  • Immunologic and Fat-Associated Predictors of Insulin Resistance in Treated HIV | NIH | 2017-07-20 - 2022-04-30 | Role: Principal Investigator
  • Microglia: dietary fat-sensitive mediators of inflammation and metabolic disease | NIH | 2015-03-01 - 2021-02-28 | Role: Principal Investigator
  • Myeloid-specific Triacylglycerol Storage in Inflammation and Metabolic Disease | NIH | 2013-03-01 - 2015-02-28 | Role: Principal Investigator
  • DGAT1: Linking Fatty Acids to Inflammation and Metabolism in White Adipose Tissue | NIH | 2009-04-01 - 2014-03-31 | Role: Principal Investigator

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
  1. ApoE-Dependent Lipid Handling by Median Eminence Microglia Preserves Myelin Integrity and Metabolic Function.
    McGrath ER, Folick A, Morrissette LJ, Brown Mayfield SM, Pham V, Pillutla SN, Choi MK, Cheang RT, Bolus WR, Schwendeman A, Ntranos V, Koliwad SK, Valdearcos M| | PubMed
  2. Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study.
    Rushakoff RJ, Rov-Ikpah E, Lee G, Mehta PB, San Luis C, Johnson C, Koliwad S, Fenton C, Kohn MA| | PubMed
  3. Inducible deletion of DGAT1 and 2 from microglia exacerbates neurodegeneration and endolysosomal lipid accumulation in male PS19 mice.
    Tabor GT, Litvinchuk A, Chen Y, Allison A, Sun EW, van Lengerich B, Davis SS, West E, Schlachetzki JCM, Zeng C, Hu H, Lin PB, Sharma P, Chen X, Parhizkar S, Song S, Bao X, Senthil L, Iyer AK, You SF, Serrano JR, Manis M, Franke E, Cashikar AG, Yuede CM, Suh JH, Karch CM, Folick A, Koliwad SK, Farese RV, Walther T, Huang EJ, Artyomov M, Glass CK, Di Paolo G, Ulrich JD, Holtzman DM| | PubMed
  4. Osteoprotegerin-Enabled Immune Evasion of Pathological Adipose Stromal Cells Drives Metabolic Dysfunction in Obesity.
    Apostolopoulou H, Wang Y, Bolus WR, Singh R, Bains A, Bahadure P, Gupta K, Koliwad SK, Bhushan A| | PubMed
  5. MON-726 Influence of Diet, Sex, and Strain on Adipose Tissue Distribution and Metabolic Risk in BXD Mouse Models.
    Jose Hernandez Nava, Stephen Brown Mayfield, Thuy An Pham, Suneil K Koliwad, Diana Lucia Alba| | UCSF Research Profile
  6. Glycation-lowering compounds inhibit ghrelin signaling to reduce food intake, lower insulin resistance, and extend lifespan.
    Wimer LA, Kaneshiro KR, Ramirez J, Bose N, Valdearcos M, Shanmugam MM, Farrera DO, Singh P, Beck J, Sellegounder D, Najera LE, Melov S, Ellerby LM, Cho SJ, Newman JC, Koliwad S, Galligan JJ, Kapahi P| | PubMed
  7. Corrigendum to 'Blocking Kv1.3 potassium channels prevents postoperative neuroinflammation and cognitive decline without impairing wound healing in mice' (Br J Anaesth 2020; 125: 298-307).
    Lai IK, Valdearcos M, Morioka K, Saxena S, Feng X, Li R, Uchida Y, Lijun A, Li W, Pan J, Koliwad S, Marcucio R, Wulff H, Maze M| | PubMed
  8. Assessment of Large Language Models for Enhancing Diabetologist-Developed Personalized Treatment Plans in Complex Type 2 Diabetes.
    Wang M, Sushil M, Williams CYK, Miao BY, Kim S, Masharani U, Ku G, Hsiao V, Shah A, Koliwad SK, Butte AJ| | PubMed
  9. Phenome-Wide Risk Evaluation of GLP-1 Receptor Agonist Use in Type 2 Diabetes with Real-World Data Across Multiple Healthcare Systems.
    Vashisht R, Dhruva SS, Patel A, Dahm L, Morris P, Gonzalez D, Follett R, Sirota M, Singh K, Han C, Koliwad S, Butte AJ| | PubMed
  10. A Distinct Form of Subcutaneous Fat Fibrosis Predicts Insulin Resistance in People with HIV.
    Alba DL, Choi MK, Abdellatif A, Brown Mayfield S, Pham TAT, Berrios D, Rodriguez A, Ewing M, Figueroa T, Gonzalez-Vargas J, Zhang N, An Z, Bu D, Deeks SG, Scherer PE, Hunt PW, Koliwad SK| | PubMed